IL2 and neoplasm: For example, the lipid-coated biodegradable hollow mesoporous silica nanoparticles with co-encapsulation of ATRA, doxorubicin and interleukin-2 (IL-2) showed great potential for developing a viable strategy to remodel the tumour immune microenvironment and achieve enhanced antitumour effect [129].